Françoise Dellu-Hagedorn1, Aurélie Fitoussi1, Philippe De Deurwaerdère2. 1. Univ. Bordeaux, F-33000 Bordeaux, France; CNRS, Institut des Neurosciences Cognitives et Intégratives d'Aquitaine UMR 5287, F-33000 Bordeaux, France. 2. Univ. Bordeaux, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. Electronic address: deurwaer@u-bordeaux.fr.
Abstract
BACKGROUND: The widespread innervation of dopamine (DA) and serotonin (5-HT) systems in cortical and subcortical regions suggests that their biochemical interactions can occur in multiple regions directly or indirectly via neurobiological networks. NEW METHOD: The present study was aimed at validating a neurochemical approach of monoaminergic function based on inter-individual variability of monoamine tissue contents in various cortical and subcortical areas. We focused on monoamines metabolism and examined correlations within and between these monoaminergic systems in selected regions for the metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and/or homovanillic acid (HVA) and 5-hydroxyindole acetic acid (5-HIAA) alone or with respect to the turnover indexes DOPAC/DA, DOPAC+HVA/DA and 5-HIAA/5-HT. RESULTS: The tissue content of metabolites and their parent drug correlated within a brain region. Conversely, a few specific relationships (10%) were observed for each turnover in paired brain regions and even less between the 5-HT and DA turnovers. The number of correlations was lower when looking at the metabolite tissue contents. In all cases, the 5-HT and DA turnover indexes or metabolites correlated positively within a brain region. COMPARISON WITH EXISTING METHOD(S): These data validate the inter-individual analysis of monoamine tissue content by providing evidence that the metabolite correlates with the parent neurotransmitter in the same region. The pattern of correlations of metabolisms reported here differs from that of the parent neurotransmitters, notably regarding the relationships of DA turnovers between striatal territories. CONCLUSION: The whole neurochemical approach is of interest for characterizing monoaminergic systems interaction in various genetic or pharmacological models of neuropsychiatric diseases.
BACKGROUND: The widespread innervation of dopamine (DA) and serotonin (5-HT) systems in cortical and subcortical regions suggests that their biochemical interactions can occur in multiple regions directly or indirectly via neurobiological networks. NEW METHOD: The present study was aimed at validating a neurochemical approach of monoaminergic function based on inter-individual variability of monoamine tissue contents in various cortical and subcortical areas. We focused on monoamines metabolism and examined correlations within and between these monoaminergic systems in selected regions for the metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and/or homovanillic acid (HVA) and 5-hydroxyindole acetic acid (5-HIAA) alone or with respect to the turnover indexes DOPAC/DA, DOPAC+HVA/DA and 5-HIAA/5-HT. RESULTS: The tissue content of metabolites and their parent drug correlated within a brain region. Conversely, a few specific relationships (10%) were observed for each turnover in paired brain regions and even less between the 5-HT and DA turnovers. The number of correlations was lower when looking at the metabolite tissue contents. In all cases, the 5-HT and DA turnover indexes or metabolites correlated positively within a brain region. COMPARISON WITH EXISTING METHOD(S): These data validate the inter-individual analysis of monoamine tissue content by providing evidence that the metabolite correlates with the parent neurotransmitter in the same region. The pattern of correlations of metabolisms reported here differs from that of the parent neurotransmitters, notably regarding the relationships of DA turnovers between striatal territories. CONCLUSION: The whole neurochemical approach is of interest for characterizing monoaminergic systems interaction in various genetic or pharmacological models of neuropsychiatric diseases.
Authors: Hugo Martin; Sébastien Bullich; Bruno P Guiard; Xavier Fioramonti; Maud Martinat; Mathilde Chataigner; Mathieu Di Miceli; Vincent Simon; Samantha Clark; Jasmine Butler; Mareike Schell; Simran Chopra; Francis Chaouloff; Andre Kleinridders; Daniela Cota; Philippe De Deurwaerdere; Luc Pénicaud; Sophie Layé Journal: Mol Psychiatry Date: 2022-10-07 Impact factor: 13.437
Authors: Philippe De Deurwaerdère; Maurizio Casarrubea; Daniel Cassar; Manuela Radic; Emilie Puginier; Abdeslam Chagraoui; Giuseppe Crescimanno; Vincenzo Crunelli; Giuseppe Di Giovanni Journal: Front Cell Neurosci Date: 2022-05-23 Impact factor: 6.147
Authors: Françoise Dellu-Hagedorn; Marion Rivalan; Aurélie Fitoussi; Philippe De Deurwaerdère Journal: Philos Trans R Soc Lond B Biol Sci Date: 2018-04-19 Impact factor: 6.237
Authors: Giuseppe Di Giovanni; Rahul Bharatiya; Emilie Puginier; Marta Ramos; Salomé De Deurwaerdère; Abdeslam Chagraoui; Philippe De Deurwaerdère Journal: Front Pharmacol Date: 2020-06-30 Impact factor: 5.810
Authors: Rahul Bharatiya; Abdeslam Chagraoui; Salomé De Deurwaerdere; Antonio Argiolas; Maria Rosaria Melis; Fabrizio Sanna; Philippe De Deurwaerdere Journal: Int J Mol Sci Date: 2020-08-09 Impact factor: 5.923
Authors: Konstantin A Demin; Anton M Lakstygal; Nataliya A Krotova; Alexey Masharsky; Natsuki Tagawa; Maria V Chernysh; Nikita P Ilyin; Alexander S Taranov; David S Galstyan; Ksenia A Derzhavina; Nataliia A Levchenko; Tatiana O Kolesnikova; Mikael S Mor; Marina L Vasyutina; Evgeniya V Efimova; Nataliia Katolikova; Andrey D Prjibelski; Raul R Gainetdinov; Murilo S de Abreu; Tamara G Amstislavskaya; Tatyana Strekalova; Allan V Kalueff Journal: Sci Rep Date: 2020-11-17 Impact factor: 4.379